| BCBS Illinois Medical Policies | Temporarily Implanted Nitinol Device (iTind) for Benign | 2026-04-01 |
| BCBS Illinois Medical Policies | Teplizumab-mzwv | 2026-04-01 |
| BCBS Illinois Medical Policies | Teprotumumab-trbw | 2026-04-01 |
| BCBS Illinois Medical Policies | Tocilizumab and Associated Biosimilar(s) | 2026-04-01 |
| BCBS Illinois Medical Policies | Triamcinolone acetonide | 2026-04-01 |
| BCBS Illinois Medical Policies | Unicondylar Interpositional Spacer as a Treatment of | 2026-04-01 |
| BCBS Illinois Medical Policies | Vedolizumab | 2026-04-01 |
| BCBS Oklahoma Medical Policies | Abatacept | 2026-04-01 |
| BCBS Oklahoma Medical Policies | Anifrolumab-fnia | 2026-04-01 |
| BCBS Oklahoma Medical Policies | Avacincaptad pegol | 2026-04-01 |